Gyre Therapeutics Inc (GYRE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 43,287 | 37,501 | 49,192 | 40,402 | 36,491 |
| Marketable Securities | 31,509 | 12,307 | 43,440 | 19,647 | 17,874 |
| Receivables | 28,015 | 22,993 | 31,308 | 26,107 | 24,859 |
| Inventories | 11,428 | 11,352 | 10,171 | 8,854 | 8,861 |
| Other current assets | 232 | 3,817 | 5,638 | 3,566 | 499 |
| TOTAL | $122,072 | $91,732 | $149,362 | $98,576 | $91,285 |
| Non-Current Assets | |||||
| PPE Net | 27,284 | 23,572 | 27,549 | 23,608 | 23,401 |
| Investments And Advances | 28,444 | 29,419 | 23,516 | 20,317 | 21,528 |
| Intangibles | 4,525 | 4,627 | 4,727 | 4,847 | 4,962 |
| Other Non-Current Assets | 16,930 | 12,665 | 14,609 | 12,036 | 11,470 |
| TOTAL | $77,183 | $70,283 | $70,401 | $60,808 | $61,361 |
| Total Assets | $199,255 | $162,015 | $219,763 | $159,384 | $152,646 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,321 | 491 | 1,562 | 784 | 290 |
| Accrued Expenses | 18,810 | 15,415 | 18,161 | 11,799 | 14,924 |
| Other current liabilities | N/A | N/A | N/A | 58 | N/A |
| TOTAL | $28,663 | $19,788 | $23,782 | $15,913 | $16,920 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 9,338 | 6,409 | 3,296 | 3,730 | 9,118 |
| TOTAL | $5,673 | $5,242 | $7,622 | $6,056 | $6,283 |
| Total Liabilities | $34,336 | $25,030 | $31,404 | $21,969 | $23,203 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 111,510 | 97,028 | 96,964 | 96,333 | 96,313 |
| Common Shares | 106 | 91 | 91 | 91 | 91 |
| Retained earnings | -137,962 | -77,667 | -112,603 | -66,703 | -70,313 |
| Other shareholders' equity | 39,701 | 39,910 | 128,052 | 36,893 | 38,228 |
| TOTAL | $164,919 | $136,985 | $188,359 | $137,415 | $129,443 |
| Total Liabilities And Equity | $199,255 | $162,015 | $219,763 | $159,384 | $152,646 |